Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic
Backlash to Trump's vaccine order on Monday has been swift and sharp, with various public health and medical organizations and independent experts calling it “dangerous,” “ unscientific,” “ false and…
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript
Wednesday, Aug. 5, 2026 at 8 a.m. ET Chief Executive Officer and Chairman of the Board - Pablo Legorreta Executive Vice President, Head of Research and Investments - Marshall Urist Chairman, Partnering and Investments - Christopher Hite Executive…
Snapchat ads pharma ad disclaimer links
This audio is auto-generated. Please let us know if you have feedback. Snapchat announced a new ad option for pharma marketers on Tuesday. The addition will let pharma advertisers include product disclosure links in their ads, making it easier for…
Why Revolution Medicines May Be Big Pharma's Next Takeover Target
RVMD has surged 492% over one year on daraxonrasib's landmark pancreatic cancer data showing 13.2 versus 6.7 months median overall survival. MRK ranks as the most likely acquirer, with Keytruda's patent cliff mounting pressure and CEO Robert Davis…
The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is
The iShares Core High Dividend ETF (NYSEARCA:HDV) leans hard on two sectors to fund its payout. Energy and pharma names account for the top four holdings, combining for 25.96% of net assets. With HDV up 19.66% year-to-date and yielding roughly 3%…
Warmington defends lobbying work for Purdue Pharma in campaign video
Democratic gubernatorial candidate Cinde Warmington has taken to social media to defend her past work as a lobbyist for Purdue Pharma, the maker of Oxycontin. The three-minute video, in which Warmington speaks directly to the camera seated on a…
FY2026 EPS Estimates for Innate Pharma Reduced by Analyst
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Equities researchers at HC Wainwright dropped their FY2026 EPS estimates for shares of Innate Pharma in a note issued to investors on Monday, August 10th. HC Wainwright analyst S.
India pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36%
India's pharmaceutical exports rose 6.80 per cent to $8.10 billion in the first quarter of FY27, with vaccine shipments surging 35.68 per cent and bulk drugs and drug intermediates growing 13.84 per cent, according to data released by the…
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB
Handelsbanken Fonder AB lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 557,028 shares of the…
Avalyn Pharma (NASDAQ:AVLN) Trading Up 8.2% Following Better-Than-Expected Earnings
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares were up 8.2% during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $39.04 and last traded at $38.35. Approximately 87,139…
BridgeBio Pharma (NASDAQ:BBIO) Given New $106.00 Price Target at Canaccord Genuity Group
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target increased by stock analysts at Canaccord Genuity Group from $104.00 to $106.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm…
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $111.00
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target lifted by equities researchers at JPMorgan Chase & Co. from $100.00 to $111.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an 'overweight'…
BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price
Innate Pharma (NASDAQ:IPHA - Get Free Report) had its price target hoisted by equities researchers at BTIG Research from $8.00 to $9.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a 'buy' rating on the…
Royalty Pharma PLC (NASDAQ:RPRX) Plans Quarterly Dividend of $0.23
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) announced a quarterly dividend on Friday, July 17th. Stockholders of record on Friday, August 14th will be given a dividend of 0.235 per share by the biopharmaceutical company on Thursday…
Q3 Earnings Forecast for aTyr Pharma Issued By HC Wainwright
aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Equities research analysts at HC Wainwright raised their Q3 2026 EPS estimates for shares of aTyr Pharma in a report released on Monday, August 10th. HC Wainwright analyst J. Pantginis now expects…
Receive a Daily briefing on Pharma Industry News
Get Started